Silver Book Fact

According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.

Houston, Kerri. Innovative Drugs Cost Patients Less in the Long Run. Chicago Sun Times. 30-Jul-2004

Reference

Title
Innovative Drugs Cost Patients Less in the Long Run
Publication
Chicago Sun Times
Publication Date
30-Jul-2004
Authors
Houston, Kerri

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Ischemic stroke patients treated with t-PA (a drug used to treat blood clots) within 3 hours of onset are 33% more likely to be free of disability 3 months after…  
  • Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.  
  • Cardiovascular disease mortality has declined by over 50% since 1950, contributing more than any other factor to the increase of life expectancy during the past few decades.  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • According to the Pharmaceutical Research and Manufacturers of America, 13 medicines are currently in development for stroke.